Larry Moreland

AIM-for-RA

National Institute of Arthritis and Musculoskeletal and Skin Diseases · UC2

PI · $7.2M · University of Rochester

Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?

National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21

PI · $494K · University of Pittsburgh at Pittsburgh

UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)

National Institute of Arthritis and Musculoskeletal and Skin Diseases · UH2

Contact PI · $1.2M · University of Pittsburgh at Pittsburgh

Randomized Observation Study of Biologic Therapy for Rheumatoid Arthritis

National Institute of Arthritis and Musculoskeletal and Skin Diseases · RC2

Contact PI · $2.9M · University of Pittsburgh at Pittsburgh

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

Principal investigator · Terminated · Phase 4

Dr. Larry W. Moreland

ACTH Gel Therapy in Rheumatoid Arthritis

Principal investigator · Completed

Dana Ascherman

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

Study chair · Terminated · Phase 4

National Institute of Allergy and Infectious Diseases (NIAID)

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Site PI · Recruiting · Phase 1

Sonoma Biotherapeutics, Inc.